Invesco Ltd. Jazz Pharmaceuticals PLC Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Invesco Ltd. holds 260,973 shares of JAZZ stock, worth $30.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

260,973

Previous 450,052 42.01%

Holding current value

$30.7 Million

Previous $48 Million 39.44%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.57 - $116.37 $19 Million - $22 Million	-189,079 Reduced 42.01%	260,973 $29.1 Million
Q2 2024 Aug 13, 2024	BUY	$103.94 - $118.98 $7.08 Million - $8.1 Million	68,096 Added 17.83%	450,052 $48 Million
Q1 2024 May 14, 2024	SELL	$115.19 - $132.77 $254,339 - $293,156	-2,208 Reduced 0.57%	381,956 $46 Million
Q4 2023 Feb 12, 2024	SELL	$114.26 - $136.0 $487,318 - $580,040	-4,265 Reduced 1.1%	384,164 $47.3 Million
Q3 2023 Nov 13, 2023	SELL	$122.0 - $145.31 $193,980 - $231,042	-1,590 Reduced 0.41%	388,429 $50.3 Million
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $15.5 Million - $18.7 Million	126,836 Added 48.19%	390,019 $48.4 Million
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $3.46 Million - $4.14 Million	25,826 Added 10.88%	263,183 $38.5 Million
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $8.73 Million - $10.8 Million	67,293 Added 39.57%	237,357 $37.8 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $581,174 - $739,977	-4,591 Reduced 2.63%	170,064 $22.7 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $50,264 - $59,874	355 Added 0.2%	174,655 $27.2 Million
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $4.12 Million - $5.1 Million	-31,757 Reduced 15.41%	174,300 $27.1 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $11.1 Million - $13.5 Million	-92,581 Reduced 31.0%	206,057 $26.3 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $7.59 Million - $10.9 Million	59,024 Added 24.63%	298,638 $38.9 Million
Q2 2021 Aug 17, 2021	SELL	$160.2 - $186.42 $12.5 Million - $14.5 Million	-78,047 Reduced 24.57%	239,614 $42.6 Million
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $4.1 Million - $4.74 Million	-27,301 Reduced 7.91%	317,661 $52.2 Million
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $24.4 Million - $28.6 Million	173,096 Added 100.72%	344,962 $56.9 Million
Q3 2020 Nov 16, 2020	BUY	$105.46 - $144.13 $1.75 Million - $2.39 Million	16,572 Added 10.67%	171,866 $24.5 Million
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $4.81 Million - $6.13 Million	50,304 Added 47.91%	155,294 $17.1 Million
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $3.88 Million - $6.75 Million	-44,184 Reduced 29.62%	104,990 $10.5 Million
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $7.24 Million - $9.46 Million	-61,511 Reduced 29.2%	149,174 $22.3 Million
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $8.54 Million - $9.78 Million	-68,257 Reduced 24.47%	210,685 $27 Million
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $8.53 Million - $9.82 Million	67,945 Added 32.2%	278,942 $39.8 Million
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $668,615 - $784,652	5,489 Added 2.67%	210,997 $30.2 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $23.8 Million - $34.3 Million	205,508 New	205,508 $25.5 Million

Others Institutions Holding JAZZ

# of Institutions

511

Shares Held

57.7M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.37B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account